Nuclidium News and Activities

Acquisition, funding and merger involving Nuclidium.

• Nuclidium has just announced a $99 Million fundraising (posted on July 14 2025).

View the org chart displaying its 14 main executives

Most searched biographies at Nuclidium

• Leila Jaafar, Chief Executive Officer
• Liliana Nordbakk, Director
• Daniel Parera, Director

Create your alert
to follow the executive moves at Nuclidium.

Nuclidium has 2,415 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• RQ Biotechnology has just announced a $86 Million fundraising (posted on June 24 2026).
• Boundless Bio has filed its IPO. Its stock ticker will be AATD. (posted on June 23 2026).
• Boundless Bio will change its company name to Serapha Bio on Dec 31, 2026. (posted on June 23 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Jan Van de Winkel - President and Chief Executive Officer at Genmab

Learn more about the Biotechnology industry

Press releases by Nuclidium

• News – Nuclidium

Social media about Nuclidium

• Nuclidium on Wikipedia, Google News & Yahoo Finance
• Nuclidium on LinkedIn, X (Twitter) & YouTube